Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), recently announced more than $200 million in funding to support …
HHS Awards Over $200 Million to Enhance Care for Older Americans Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) reports that a dairy farm worker in Colorado has been diagnosed with avian influenza A(H5), marking the state’s first …
Colorado Reports First Human Case of Avian Influenza Amid Multistate Outbreak Read More
WASHINGTON, D.C. — On Tuesday, the Food and Drug Administration (FDA) approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. This approval marks a major milestone in the fight …
FDA Approves Kisunla for Alzheimer’s Treatment, Marking Significant Progress Read More
WASHINGTON, D.C. — On Monday, the FDA’s Center for Devices and Radiological Health (CDRH) announced the continued expansion of its Total Product Life Cycle (TPLC) Advisory Program. This program, initially …
FDA Expands Total Product Life Cycle Advisory Program to Accelerate Medical Device Development Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that the national supply of cisplatin, a key cancer medication, now exceeds demand, ending a critical shortage that began …
FDA Announces End to National Shortage of Crucial Cancer Drug Cisplatin Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has issued a warning to parents about the dangers of using benzocaine or lidocaine to treat teething pain in infants and …
FDA Warns Against Using Benzocaine and Lidocaine for Teething Pain in Children Read More WASHINGTON, D.C. — The FDA recently announced a new collaboration with the Bill and Melinda Gates Foundation aimed at developing breath-based diagnostic devices to detect infectious diseases in underserved populations. …
FDA Partners with Gates Foundation to Develop Breath-Based Diagnostics for Infectious Diseases Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval to Epkinly (epcoritamab-bysp), a new treatment option for adults with relapsed or refractory follicular lymphoma (FL). This …
FDA Grants Accelerated Approval to New Treatment for Relapsed Follicular Lymphoma Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) recently disclosed the encouraging results of its Phase III clinical trial related to Parkinson’s disease treatment. The experimental drug, buntanetap, has shown …
Annovis Bio’s Breakthrough in Parkinson’s Treatment: New Drug Buntanetap Shows Promise Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) has released new survey results highlighting persistent drug shortages in cancer treatment across the United States. While the availability of …
NCCN Survey Reveals Ongoing Cancer Drug Shortages Despite Improvements Read More